MetaCure
Kfar Saba, HaMerkaz, Israel
About MetaCure
MetaCure develops implantable devices for the treatment of Type II (adult) diabetes. Their key product, Tantalus, delivers electrical pulses to the stomach when a person eats, causing gastric contractions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2009)
- Website: metacure.com
- Phone: +97297680376
Industries & Categories
Biotechnology, Diabetes, Electronics
Social Profiles
Canonical: https://fsome.com/organization/metacure-2538616 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.